Alopexx, Inc. (ALPX)
Alopexx will go public soon, but the exact IPO date is still unknown.
IPO Price
$5.00
Shares Offered
2,400,000
Deal Size
$12.00M
Alopexx Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
37.96M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionALPX News
- 2 years ago - Alopexx To Raise ~$15m IPO With Ambition To Drive Blockbuster Sales As Prevnar's Partner - Seeking Alpha
- 2 years ago - IPO Update: Alopexx Readies $15 Million U.S. IPO - Seeking Alpha
- 2 years ago - Alopexx IPO Registration Document (S-1) - SEC
- 3 years ago - Biopharma financings cut by a third, transactions track with 2019 and earlier - BioWorld
- 3 years ago - Infectious disease biotech Alopexx files for a $17 million IPO - Renaissance Capital